GENEVA, July 8 -- FORTVITA BIOLOGICS (SINGAPORE) PTE. LTD. (38 Beach Road, #29-11 South Beach Tower189767), 福佑泰生物制药(新加坡)公司 (新加坡新加坡美芝路38号南海滩大厦#29-11) filed a patent application (PCT/CN2024/143132) for "PD-1/IL-2R BISPECIFIC ANTIBODY FUSION PROTEIN, AND USE AND USAGE METHOD THEREOF" on Dec 27, 2024. With publication no. WO/2025/140535, the details related to the patent application was published on Jul 03, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the Wor...